ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,299, issued on Dec. 30, was assigned to METROHEALTH VENTURES LLC (Cleveland).
"Compositions and methods for treating obesity and hyperphagia" was invented by M. Michael Wolfe (Bal Harbour, Fla.) and Michael O. Boylan (Milton, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to the treatment of diseases or conditions characterized by the buildup of fatty tissue, or hyperphagia, such as Prader-Willi syndrome, obesity, metabolic syndrome, type II diabetes, etc. A composition containing a monoclonal antibody directed against gastric inhibitory polypeptide is administered. This results in a reduced rate of weight ga...